We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$61.7M
AUM Growth
–
Cap. Flow
+$61.1M
Cap. Flow %
98.96%
Top 10 Hldgs %
41.2%
Holding
424
New
424
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.45M
2
GILD icon
Gilead Sciences
GILD
+$3.41M
3
ROST icon
Ross Stores
ROST
+$3.25M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.18M
5
FISV
Fiserv Inc
FISV
+$3.04M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 27.73%
2 Industrials 11.95%
3 Consumer Discretionary 11.44%
4 Energy 9.7%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARMK icon
351
Aramark
ARMK
$14.7B
$573 ﹤0.01%
+22
New +$626
OKE icon
352
Oneok
OKE
$54.5B
$572 ﹤0.01%
+9
New +$598
KDP icon
353
Keurig Dr Pepper
KDP
$40.8B
$564 ﹤0.01%
+16
New +$562
MRVL icon
354
Marvell Technology
MRVL
$196B
$563 ﹤0.01%
+13
New +$547
BAH icon
355
Booz Allen Hamilton
BAH
$9.15B
$556 ﹤0.01%
+6
New +$569
KHC icon
356
Kraft Heinz
KHC
$30B
$541 ﹤0.01%
+14
New +$554
AVY icon
357
Avery Dennison
AVY
$13.4B
$537 ﹤0.01%
+3
New +$545
RVTY icon
358
Revvity
RVTY
$12.8B
$533 ﹤0.01%
+4
New +$527
NTES icon
359
NetEase
NTES
$84.7B
$531 ﹤0.01%
+6
New +$517
LRCX icon
360
Lam Research
LRCX
$390B
$530 ﹤0.01%
+10
New +$491
TEL icon
361
TE Connectivity
TEL
$62.6B
$525 ﹤0.01%
+4
New +$506
AEE icon
362
Ameren
AEE
$30.1B
$518 ﹤0.01%
+6
New +$514
NBIX icon
363
Neurocrine Biosciences
NBIX
$16.6B
$506 ﹤0.01%
+5
New +$520
IDXX icon
364
Idexx Laboratories
IDXX
$46.2B
$500 ﹤0.01%
+1
New +$479
ON icon
365
ON Semiconductor
ON
$31.6B
$494 ﹤0.01%
+6
New +$456
AMD icon
366
Advanced Micro Devices
AMD
$789B
$490 ﹤0.01%
+5
New +$407
WEC icon
367
WEC Energy
WEC
$35.1B
$474 ﹤0.01%
+5
New +$463
SWKS icon
368
Skyworks Solutions
SWKS
$10.6B
$472 ﹤0.01%
+4
New +$443
XEL icon
369
Xcel Energy
XEL
$48.8B
$472 ﹤0.01%
+7
New +$472
DXCM icon
370
DexCom
DXCM
$32B
$465 ﹤0.01%
+4
New +$448
IR icon
371
Ingersoll Rand
IR
$33.7B
$465 ﹤0.01%
+8
New +$451
BIDU icon
372
Baidu
BIDU
$37.2B
$453 ﹤0.01%
+3
New +$425
SRE icon
373
Sempra
SRE
$54.8B
$453 ﹤0.01%
+6
New +$460
CSL icon
374
Carlisle Companies
CSL
$15.4B
$452 ﹤0.01%
+2
New +$486
CHD icon
375
Church & Dwight Co
CHD
$24.5B
$442 ﹤0.01%
+5
New +$417
13 14
15
16 17

Similar funds

TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return
DA
Drake & Associates Waukesha, Wisconsin $525M AUM 14.04% 1-Year Est. Return
SRFM
Shannon River Fund Management New York $524M AUM 90.54% 1-Year Est. Return

USA Financial Formulas's Q1 2023 Portfolio in Review

Q1 2023 is the first quarter with a 13F filing on record for USA Financial Formulas, which disclosed 424 positions worth $61.7M. Its ten largest holdings account for 41% of the portfolio.

Its largest position is Biogen: 12,485 shares worth $3.47M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, followed by Industrials and Consumer Discretionary.

  • USA Financial Formulas's largest Q1 2023 buy was Biogen: 12,485 shares worth $3.47M.
  • USA Financial Formulas's ten largest holdings make up 41% of its $61.7M portfolio in Q1 2023.
  • USA Financial Formulas disclosed 424 positions in Q1 2023, its first 13F filing on record.

Based on USA Financial Formulas's 13F filing for Q1 2023, filed 27 Nov 2023.